Inflammatory bowel disease (IBD) is an umbrella term referring to two chronic idiopathic intestinal diseases: ulcerative colitis (UC) and Crohn’s disease (CD). Both UC and CD are characterized by immune activation that leads to symptoms, but the location, severity and behavior of the inflammation varies among individuals and in characteristic ways between UC and CD. A majority of patients with IBD are diagnosed in young adulthood, but the response to therapy is variable and difficult to predict, with some patients demonstrating a prompt and effective remission while others have continuous symptoms that do not respond to existing medical options. Surgery remains a frequent and necessary occurrence among patients with IBD, but in UC it is considered curative, while in CD only temporizing. Clinical observations, epidemiological studies, and molecular genetics have provided strong evidence that both genetic and environmental factors are important determinants for disease susceptibility. In recent years, a number of genes have been identified that associate with CD and UC, although the clinical utility of these discoveries in patients or in susceptible family members has not been determined. Nonetheless, it is hoped that these fundamental advances in our understanding of IBD will lead to better therapies for patients and prevention strategies for those who are susceptible. Effective incorporation of clinical genetic testing for IBD into practice will require appropriate education and counseling.
Similar content being viewed by others
References
Aktan-Collan, K., Haukkala, A., et al. (2001). Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): A prospective follow-up study. Int J Cancer, 93(4), 608–611.
Allchin, W. H. (1909). Ulcerative Colitis, An address introductory to the subject. Proc R Soc Med, 2, 59–175.
Alvarez-Lobos, M., Arostegui, J. I., Sans, M., et al. (2005). Alvarez-Lobos M, Arostegui JI, Sans M, Tassies D, Plaza S, Delgado S, Lacy AM, Pique JM, Yague J, Panes J. Ann Surg, 242(5), 693–700. Crohn’s disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence.
Andres, P. G., & Friedman, L. S. (1999). Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am, 28(2), 255–281, vii.
Annese, V., Andreoli, A., Astegiano, M., et al. (2001). Clinical features in familial casesof Crohn’s disease and ulcerative colitis in Italy: A GISC Study. Italian study group for the disease of colon and rectum. Am J Gastroenterol, 96, 2939–2945.
Aronowitz, R. A. (1998). The rise and fall of the hPsychosomatic Hypothesis in Ulcerative Colitis. In R. A. Aronowitz (Ed.): Making sense of illness (pp. 57–83). New York, NY: Cambridge University Press.
Babul, R., Adam, S., et al. (1993). Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease. JAMA, 270(19), 2321–2325.
Basset, C., Holton, J., et al. (2004). Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig Dis Sci, 49(9), 1425–1432.
Bernstein, C. N., Blanchard, J. F., et al. (2001). Cancer risk in patients with inflammatory bowel disease: A population-based study. Cancer, 91(4), 854–862.
Bernstein, C. N., Blanchard, J. F., et al. (1999). Epidemiology of CD and ulcerative colitis in a central Canadian province: A population-based study. Am J Epidemiol, 149(10), 916–924.
Bonen, D, & Cho, J. (2003). The Genetics of Inflammatory Bowel Disease. Gastroenterology, 124, 521–536.
Bottorff, J. L., Ratner, P. A., Balneaves, L. G., et al. (2002). Women’s interest in genetic testing for breast cancer risk the influence of sociodemographics and knowledge. Cancer Epidemiol Biomarkers & Prevent, 11, 89–95.
Brant, S. R., Picco, M. F., Achkar, J. P., et al. (2003). Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn’s disease phenotypes. Inflamm Bowel Dis, 9(5), 281–289.
Bratt, O., Damber, J. E., Emanuelsson, M., et al. (2000). Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer, 36(2), 235–241.
Calkins, B. M. (1989) A Meta-Analysis of the Role of Smoking in Inflammatory Bowel Disease. Dig Dis Sci 34, 1841–1854.
Carr, I., & Mayvberry, J. F. (1999). The effects of migration on ulcertive colitis: A three-year prospective study among Europeans and first- and second-generation South Asians in Leicester (1991–1994). Am J Gastroenterol, 94, 2918–2922.
Cavanaugh, J. A., Adams, K. E., et al. (2003). CARD15/NOD2 risk alleles in the development of CD in the Australian population. Ann Hum Genet, 67(Pt 1), 35–41.
Cho, J. H., Nicolae, D. L., et al. (1998). Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: Evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A, 95(13), 7502–7507.
Cosnes, J. (2004). Tobacco and IBD: Relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol, 18(3), 481–496.
Cuffari, C., Hunt, S., Bayless, E. (2001). Utilisation of erythrocyte-thioguanine metabolite levels to optimise azaththioprine therapyu in patiens with inflammatory bowel disease. Gut, 48, 642–466.
Dashiell, G. F., Kirsner, J. B., Kotz, A. P., et al. (1951). Regional enteritis: A follow-up Stud of Forty Cases. Med Clin North Am, 35, 227–241.
De Boer, M., Grootenhuis, M., Derkx, B., & Last, B. (2005). Health-related Quality of Life and Psychosocial Functioning of Adolscents with Inflammatory Bowel Disease. Inflamm Bowel Dis, 11(4), 400–406.
Duerr, R. H., Barmada, M. M., et al. (2000). High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am J Hum Genet, 66(6), 1857–1862.
Esters, N., Pierik, M., et al. (2004). Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease. Am J Gastroenterol, 99(2), 299–305.
Farmer, R. G., Michener, W. M., et al. (1980). Studies of family history among patients with inflammatory bowel disease. Clin Gastroenterol, 9(2), 271–277.
Florin, T. H., Pandeya, N., et al. (2004). Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: Its influence on the clinical behaviour of these diseases. Gut, 53(7), 973–979.
Frisch, M., Olsen, J., & Andersen, P. K. (1996). Follow-up time bias and Crohn’s disease. Lancet, 347, 1551.
Galbraith, S. S., Drolet, B. A., Kugathasan, S., Paller, A. S., & Esterly, N. B. (2005). Asymptomatic inflammatory bowel disease presenting with mUC ocutaneous findings. Pediatrics, 116(3), e439–e444.
Gleason, T. R., & Evans, M. E. (2004). Perceived vulnerability: A comparison of parents and children. J Child Health Care, 8(4), 279–287.
Gonzalez, S., Rodrigo, L., Martinez-Borra, J., et al. (2003). TNF-alpha -308A promotor polymorphism is assoicated with enhanced TNF-alpha production and inflmmatory activity in Crohn’s patients with fistulizing disease. Am J Gastroenterol, 98, 1101–1106.
Grosse, S. D., Khoury, M. J. (2006). What is the clinical utility of Genetic Testing? Genetics IN Medicine, 8(7), 448–450.
Halfvarson, J., Bodin, L., Tysk, C., et al. (2003). inflammatory bowel disease in a swedish cohort: A long-term follow-up of concordance and clinical characteristics. Gastroenterology, 124, 1067–1773.
Hampe, J., Heymann, K., Kruis, W., et al. (2000). Anticipation in Inflammatory Bowel Disease: A Phenomenon Caused by an Accumulation of Confounders. Am J Gastroenterol, 92, 178–183.
Hampe, J., Cuthbert, A., et al. (2001). Association between insertion mutation in NOD2 gene and CD in German and British populations. Lancet, 357(9272), 1925–1928.
Hampe, J., Shaw, S. H., et al. (1999). Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet, 65(6), 1647–1655.
Holtzman, N. A., & Watson, M. S. (Eds) (1997). Promoting safe and effective genetic testing in the United States. Final Report of the Task Force on Genetic Testing. http://www.genome.gove/10001733. Accessed August 7, 2006.
Hugot, J. P., Chamaillard, M., et al. (2001). Association of NOD2 leUC ine-rich repeat variants with susceptibility to CD. Nature, 411(6837), 599–603.
Jick, H., & Walker, A. M. (1983). Cigarette smoking and ulcerative colitis. N Engl J Med, 308(5), 261–263.
Kessler, S., Field, T., et al. (1987). Attitudes of persons at risk for Huntington disease toward predictive testing. Am J Med Genet, 26(2), 259–270.
Konda, V., Huo, D., Hermes, G., Liu, M., Patel, R., & Rubin, D. T. (2006). Do Patients with Inflammatory Bowel Disease Want Genetic Testing? Inflamm Bowel Dis, 12(6), 497–502.
Kornbluth, A., Sachar, D. B., Practice Parameters Committee of the American College of Gastroenterology. (2004). Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol, 99(7), 1371–1385.
Kruiningen, H. J. V., Joossens, M., Vermeire, S., et al. (2005). Environmental Factors in Familial Crohn’s Disease in Belgium. Inflamm Bowel Dis, 11(4), 360–365.
Kugathasan, S., Collins, N., Maresso, K., et al. (2004). CARD15 Gene Mutations and Risk for Early Surgery in Pediatric-Onset CD. Clin Gastroenterol Hepatol, 2(11), 1003–1009.
Kurata, J. H., Kantor-Fish, S., et al. (1992). CD among ethnic groups in a large health maintenance organization. Gastroenterology, 102(6), 1940–1948.
Langholz, E., Munkholm, P., et al. (1991). Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol, 26(12), 1247–1256.
Louis, E., Peeters, M., Franchimont, D., et al. (2000) Tumour necrosis factor (TNF) gene polymorphism in Crohn’s disease (CD): Influence on disease behaviour? Clin Exp Immunol, 119, 64–68.
Loftus, E. (2004). Clinical Epidemiology of Inflammatory Bowel Disease: Incidence, PRevalence, and Environmental Influences. Gastroenterology, 126, 1504–1517.
Loftus, E. V., Jr., Silverstein, M. D., et al. (1998). CD in Olmsted County, Minnesota, 1940–1993: Incidence, prevalence, and survival. Gastroenterology, 114(6), 1161–1168.
Ma, Y., Ohmen, J. D., et al. (1999). A genome-wide search identifies potential new susceptibility loci for CD. Inflamm Bowel Dis, 5(4), 271–278.
McConnell, R. B. (1983). Ulcerative colitis - genetic features. Scand J Gastroenterol 88(Supplement), 14–16.
McInerney-Leo, A., Biesecker, B. B., et al. (2004). BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention. Am J Med Genet A, 130(3), 221–227.
Monsen, U., Bernell, O., et al. (1991). Prevalence of inflammatory bowel disease among relatives of patients with CD. Scand J Gastroenterol, 26(3), 302–306.
Monsen, U., Iselius, L., et al. (1989). Evidence for a major additive gene in ulcerative colitis. Clin Genet, 36(6), 411–414.
Myers, M. F., Chang, M. H., Jorgensen, C., et al. (2006) Genetic testing for susceptibility to breast and ovarian cancer: Evaluating the impact of a direct-to-consumer marketing campaign on physicians’ knowledge and practices. Genet Med, 8(6), 361–370.
Negoro, K., Kinouchi, Y., Iwatashi, H., et al. (1999). Crohn’s disease is associated with novel polymorphism in the 5’-flanking region of th tumor necrosis factor gene. Gastroenterology, 117, 1062–1068.
Nemetz, A., Nosti-Escanilla, M. P., Molnar, T., et al (1999). IL1B gene polymorphism influences the course and severity of inflammatory bowel disease. Immunogenetics, 49, 527–531.
Neuhausen S. (1999). Ethnic Differences in Cancer Risk Resulting from Genetic Variation. Cancer, 86, 2575–2582.
Ogunbi, S. O., Ransom, J. A., et al. (1998). Inflammatory bowel disease in African-American children living in Georgia. J Pediatr, 133(1), 103–107.
Ohmen, J. D., Yang, H. Y., et al. (1996). Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in CD, but not in ulcerative colitis. Hum Mol Genet, 5(10), 1679–1683.
Oliva-Hemker, M., & Fiocchi, C. (2002). Etiopathogenesis of inflammatory bowel disease: The importance of the pediatric perspective. Inflamm Bowel Dis, 8(2), 112–128.
Orholm, M., Binder, V., et al. (2000). Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol, 35(10), 1075–1081.
Orholm, M., Iselius, L., et al. (1993). Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. BMJ, 306(6869), 20–24.
Pace, F., Molteni, P., Bollani, S., Sarzi-Puttini, P., Stockbrugger, R., Porro, G. B., Drossman, D. A. (2003). Inflammatory bowel disease versus irritable bowel syndrome: A hospital-based, case-control study of disease impact on quality of life. Scand J Gastroenterol, 38(10), 1031–1038.
Pearson, S. R., & Boyce, W. T. (2004). Consultation with the Specialist: The Vulnerable Child Syndrome. Pediatrics Rev, 25, 345–349.
Peltekova, V. D., Wintle, R. F., Rubin, L. A., et al. (2004). Functional variants of OCTN cation transporter genes are associated with Crohn Disease. Nature Genet, 36(5), 471–475.
Polito, J. M. (1996). Preliminary evidence for genetic anticipation in Crohn’s disease. Lancet, 347, 798–800.
Rioux, J. D., Silverberg, M. S., et al. (2000). Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet, 66(6), 1863–1870.
Roth, M. P., Petersen, G. M., et al. (1989). Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology, 96(4), 1016–1020.
Roussomoustakiki, M., Satsangi, J., Welsh, K., et al. (1997) Genetic markers may predict disease behaviour i patiens with ulcerative colitis. Gastroenterology, 112, 1845–1853.
Rubin, D. T., Konda, V., Lewis, J. R. (2005). Genetic testing for IBD: Focus group analysis of patients and family members. Gastroenterology, 128(4), abstract.
Russel, M. G., Pastoor, C. J., et al. (1997). Familial aggregation of inflammatory bowel disease: A population-based study in South Limburg, The Netherlands. The South Limburg IBD Study Group. Scand J Gastroenterol Suppl, 223, 88–91.
Russell, R. K., Satsangi, J.,(2004), IBD: A family affair. Best Pract Res Clin Gastroenterol, 18(3), 525–539.
Sandler, R. S., Sandler, D. P., McDonnell, C. W., et al. (1992). Childhood exposure to environmental tobacco smoke and the risk of ulcerative colitis. Am J Epidemio, 135, 603–608.
Satsangi, J., Grootscholten, C., Holt, H., & Jewell, D. P. (1996). Clinical patterns of Familial Inflammatory Bowel Disease. Gut, 38, 738–741.
Satsangi, J., Jewell, D. P., et al. (1997). The genetics of inflammatory bowel disease. Gut, 40(5), 572–574.
Scheiner, A. P., Sexton, M. E., Rockwood, J., et al. (1985). The vulnerable child syndrome: Fact and theory. J Dev Behav Pediatr, 6(5), 298–301.
Sewitch, M. J., Abrahamowicz, M., Bitton, A., et al. (2001) Psychological distress, social support, and disease activity in patients with inflammatory bowel disease. Am J Gastroenterol (United States), 96(5), 1470–1479.
Shivananda, S., Lennard-Jones, J., et al. (1996). Incidence of inflammatory bowel disease across Europe: Is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut, 39, 690–697.
Tercyak, K. P., Lerman, C., et al. (2001). Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk. Health Psychol, 20(3), 217–222.
Thomas, G. A., Millar-Jones, D., et al. (1995). Incidence of CD in Cardiff over 60 years: 1986–1990 an update. Eur J Gastroenterol Hepatol, 7(5), 401–405.
Thomasgard, Trallori, G., Palli, D., et al. (1997). A population-based study of inflammatory bowel disease in Florence over 15 years (1978–92). Scand J Gastroenterol, 31(9), 892–899.
Trachter, A. B., Rogers, A. I., & Leiblum, S. R. (2002) Inflammatory bowel disease in women: Impact on relationship and sexual health. Inflamm Bowel Dis (United States), 8(6), 413–421.
Vare, P. O., Heikius, B., et al. (2001). Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: Is Helicobacter pylori infection a protective factor? Scand J Gastroenterol, 36(12), 1295–1300.
Vera, A., Gunson, B. K., et al. (2003). Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation, 75(12), 1983–1988.
Watts, D. A., & Satsangi, J. (2002). The genetic jigsaw of inflammatory bowel disease. Gut, 50(Suppl III), iii31–iii36.
Wertz, D. C., & Gregg, R. (2000). Genetics services in a social, ethical and policy context: A collaboration between consumers and providers. J Med Ethics, 26(4), 261–265.
Weterman, I. T., & Pena, A. S. (1984). Familial incidence of Crohn’s disease in the Netherlands and a review of the literature. Gastroenterology, 35, 93–99.
Yang, H., Taylor, K. D., et al. (2001). Inflammatory bowel disease. I. Genetic epidemiology. Mol Genet Metab, 74(1–2), 1–21.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cummings, S.A., Rubin, D.T. The Complexity and Challenges of Genetic Counseling and Testing for Inflammatory Bowel Disease. J Genet Counsel 15, 465–476 (2006). https://doi.org/10.1007/s10897-006-9057-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-006-9057-0